Occludin oligomeric assembly at tight junctions of the blood-brain barrier is disrupted by peripheral inflammatory hyperalgesia

Journal of Neurochemistry

Volumn 106, Issue 6, 2008, Pages 2395-2409

  McCaffrey, Gwen ^a   Seelbach, Melissa J ^a   Staatz, William D ^a   Nametz, Nicole ^a   Quigley, Carolyn ^a   Campos, Chris R ^a   Brooks, Tracy A ^b   Davis, Thomas P ^a,b  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b BIO5 Institute   (United States)

Author keywords

Blood brain barrier; Density gradient; Inflammatory pain; Occludin; Tight junction; Trafficking

Indexed keywords

CARRAGEENAN; DODECYL SULFATE SODIUM; MEMBRANE LIPID; OCCLUDIN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; COMPLEX FORMATION; CONTROLLED STUDY; DENSITY GRADIENT CENTRIFUGATION; ENDOTHELIUM CELL; FEMALE; HYPERALGESIA; INFLAMMATION; LIPID RAFT; NONHUMAN; OLIGOMERIZATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN LOCALIZATION; RAT; TIGHT JUNCTION; WESTERN BLOTTING;

ANIMALS; BIOLOGICAL TRANSPORT, ACTIVE; BLOOD-BRAIN BARRIER; CARRAGEENAN; CELL COMPARTMENTATION; DIFFUSION; ENDOTHELIAL CELLS; FEMALE; HYPERALGESIA; INFLAMMATION; MACROMOLECULAR SUBSTANCES; MEMBRANE MICRODOMAINS; MEMBRANE PROTEINS; MICROCIRCULATION; PROTEIN BINDING; PROTEIN SUBUNITS; RATS; RATS, SPRAGUE-DAWLEY; TIGHT JUNCTIONS;

RATTUS;

EID: 50849106047     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2008.05582.x     Document Type: Article

References (87)

1. Andersson J. (2005) The inflammatory reflex - introduction. J. Intern. Med., 257, 122 125.
2. Balda M. S., Flores-Maldonado C., Cereijido M. Matter K. (2000) Multiple domains of occludin are involved in the regulation of paracellular permeability. J. Cell. Biochem., 78, 85 96.
3. Barrios-Rodiles M., Brown K. R., Ozdamar B. et al. (2005) High-throughput mapping of a dynamic signaling network in mammalian cells. Science, 307, 1621 1625.
4. Blasig I. E., Winkler L., Lassowski B. et al. (2006) On the self-association potential of transmembrane tight junction proteins. Cell. Mol. Life Sci., 63, 505 514.
5. de Boer A. G. Gaillard P. J. (2007) Drug targeting to the brain. Annu. Rev. Pharmacol. Toxicol., 47, 323 355.
6. Brooks T. A., Hawkins B. T., Huber J. D., Egleton R. D. Davis T. P. (2005) Chronic inflammatory pain leads to increased blood-brain barrier permeability and tight junction protein alterations. Am. J. Physiol. Heart Circ. Physiol., 289, H738 H743.
7. Brooks T. A., Ocheltree S. M., Seelbach M. J., Charles R. A., Nametz N., Egleton R. D. Davis T. P. (2006) Biphasic cytoarchitecture and functional changes in the BBB induced by chronic inflammatory pain. Brain Res., 1120, 172 182.
8. Ceroni A., Passerini A., Vullo A. Frasconi P. (2006) DISULFIND: a disulfide bonding state and cysteine connectivity prediction server. Nucleic Acids Res., 34, W177 W181.
9. Chen Y. H. Lu Q. (2003) Association of nonreceptor tyrosine kinase c-yes with tight junction protein occludin by coimmunoprecipitation assay. Methods Mol. Biol., 218, 127 132.
10. Chung N. P., Mruk D., Mo M. Y., Lee W. M. Cheng C. Y. (2001) A 22-amino acid synthetic peptide corresponding to the second extracellular loop of rat occludin perturbs the blood-testis barrier and disrupts spermatogenesis reversibly in vivo. Biol. Reprod., 65, 1340 1351.
11. DeMaio L., Rouhanizadeh M., Reddy S., Sevanian A., Hwang J. Hsiai T. K. (2006) Oxidized phospholipids mediate occludin expression and phosphorylation in vascular endothelial cells. Am. J. Physiol. Heart Circ. Physiol., 290, H674 H683.
12. Desai B. S., Monahan A. J., Carvey P. M. Hendey B. (2007) Blood-brain barrier pathology in Alzheimer's and Parkinson's disease: implications for drug therapy. Cell Transplant, 16, 285 299.
13. Dobrogowska D. H. Vorbrodt A. W. (2004) Immunogold localization of tight junctional proteins in normal and osmotically-affected rat blood-brain barrier. J. Mol. Histol., 35, 529 539.
14. Edman J. C., Ellis L., Blacher R. W., Roth R. A. Rutter W. J. (1985) Sequence of protein disulphide isomerase and implications of its relationship to thioredoxin. Nature, 317, 267 270.
15. Everett R. S., Vanhook M. K., Barozzi N., Toth I. Johnson L. G. (2006) Specific modulation of airway epithelial tight junctions by apical application of an occludin peptide. Mol. Pharmacol., 69, 492 500.
16. Feldman G. J., Mullin J. M. Ryan M. P. (2005) Occludin: structure, function and regulation. Adv. Drug Deliv. Rev., 57, 883 917.
17. Fischer S., Wiesnet M., Renz D. Schaper W. (2005) H2O2 induces paracellular permeability of porcine brain-derived microvascular endothelial cells by activation of the p44/42 MAP kinase pathway. Eur. J. Cell Biol., 84, 687 697.
18. Forster C. (2008) Tight junctions and the modulation of barrier function in disease. Histochem. Cell Biol., 130, 55 70.
19. Furuse M., Itoh M., Hirase T., Nagafuchi A., Yonemura S., Tsukita S. Tsukita S. (1994) Direct association of occludin with ZO-1 and its possible involvement in the localization of occludin at tight junctions. J. Cell Biol., 127, 1617 1626.
20. Gonzalez-Mariscal L., Tapia R. Chamorro D. (2008) Crosstalk of tight junction components with signaling pathways. Biochim. Biophys. Acta, 1778, 729 756.
21. Hansson E. Zugner R. 2005) Can chronic pain and spreading of pain be induced via glial mechanisms? New hypotheses on the generators maintaining protracted pain conditions. Lakartidningen, 102, 3552, 3555 3556, 3558.
22. Hargreaves K., Dubner R., Brown F., Flores C. Joris J. (1988) A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain, 32, 77 88.
23. Harhaj N. S. Antonetti D. A. (2004) Regulation of tight junctions and loss of barrier function in pathophysiology. Int. J. Biochem. Cell Biol., 36, 1206 1237.
24. Hau V. S., Huber J. D., Campos C. R., Davis R. T. Davis T. P. (2004) Effect of lambda-carrageenan-induced inflammatory pain on brain uptake of codeine and antinociception. Brain Res., 1018, 257 264.
25. Hawkins B. T. Davis T. P. (2005) The blood-brain barrier/neurovascular unit in health and disease. Pharmacol. Rev., 57, 173 185.
26. Hendset M., Haslemo T., Rudberg I., Refsum H. Molden E. (2006) The complexity of active metabolites in therapeutic drug monitoring of psychotropic drugs. Pharmacopsychiatry, 39, 121 127.
27. Hirase T., Kawashima S., Wong E. Y., Ueyama T., Rikitake Y., Tsukita S., Yokoyama M. Staddon J. M. (2001) Regulation of tight junction permeability and occludin phosphorylation by Rhoa-p160ROCK-dependent and -independent mechanisms. J. Biol. Chem., 276, 10423 10431.
28. Hogg P. J. (2003) Disulfide bonds as switches for protein function. Trends Biochem. Sci., 28, 210 214.
29. Hotchkiss K. A., Matthias L. J. Hogg P. J. (1998) Exposure of the cryptic Arg-Gly-Asp sequence in thrombospondin-1 by protein disulfide isomerase. Biochim. Biophys. Acta, 1388, 478 488.
30. Huber J. D., Witt K. A., Hom S., Egleton R. D., Mark K. S. Davis T. P. (2001) Inflammatory pain alters blood-brain barrier permeability and tight junctional protein expression. Am. J. Physiol. Heart Circ. Physiol., 280, H1241 H1248.
31. Huber J. D., Hau V. S., Borg L., Campos C. R., Egleton R. D. Davis T. P. (2002) Blood-brain barrier tight junctions are altered during a 72-h exposure to lambda-carrageenan-induced inflammatory pain. Am. J. Physiol. Heart Circ. Physiol., 283, H1531 H1537.
32. Huber J. D., Campos C. R., Mark K. S. Davis T. P. (2006) Alterations in blood-brain barrier ICAM-1 expression and brain microglial activation after lambda-carrageenan-induced inflammatory pain. Am. J. Physiol. Heart Circ. Physiol., 290, H732 H740.
33. Ibuki T., Matsumura K., Yamazaki Y., Nozaki T., Tanaka Y. Kobayashi S. (2003) Cyclooxygenase-2 is induced in the endothelial cells throughout the central nervous system during carrageenan-induced hind paw inflammation; its possible role in hyperalgesia. J. Neurochem., 86, 318 328.
34. Jin Y., Uchida I., Eto K., Kitano T. Abe S. (2008) Size-selective junctional barrier and Ca(2+)-independent cell adhesion in the testis of Cynops pyrrhogaster: expression and function of occludin. Mol. Reprod. Dev., 75, 202 216.
35. Jordan P. A. Gibbins J. M. (2006) Extracellular disulfide exchange and the regulation of cellular function. Antioxid. Redox Signal., 8, 312 324.
36. Kago T., Takagi N., Date I., Takenaga Y., Takagi K. Takeo S. (2006) Cerebral ischemia enhances tyrosine phosphorylation of occludin in brain capillaries. Biochem. Biophys. Res. Commun., 339, 1197 1203.
37. Kaur C. Ling E. A. (2008) Blood brain barrier in hypoxic-ischemic conditions. Curr. Neurovasc. Res., 5, 71 81.
38. 2-mediated permeability: role of MAPK and occludin. Am. J. Physiol. Cell Physiol., 279, C21 C30.
39. Krause G., Winkler L., Mueller S. L., Haseloff R. F., Piontek J. Blasig I. E. (2008) Structure and function of claudins. Biochim. Biophys. Acta, 1778, 631 645.
40. Krizbai I. A., Bauer H., Bresgen N., Eckl P. M., Farkas A., Szatmari E., Traweger A., Wejksza K. Bauer H. C. (2005) Effect of oxidative stress on the junctional proteins of cultured cerebral endothelial cells. Cell. Mol. Neurobiol., 25, 129 139.
41. Kyte J. Doolittle R. F. (1982) A simple method for displaying the hydropathic character of a protein. J. Mol. Biol., 157, 105 132.
42. Lacaz-Vieira F., Jaeger M. M., Farshori P. Kachar B. (1999) Small synthetic peptides homologous to segments of the first external loop of occludin impair tight junction resealing. J. Membr. Biol., 168, 289 297.
43. Lapierre L. A., Tuma P. L., Navarre J., Goldenring J. R. Anderson J. M. (1999) VAP-33 localizes to both an intracellular vesicle population and with occludin at the tight junction. J. Cell Sci., 112 (Pt 21 3723 3732.
44. Lloyd R. V., Vidal S., Horvath E., Kovacs K. Scheithauer B. (2003) Angiogenesis in normal and neoplastic pituitary tissues. Microsc. Res. Tech., 60, 244 250.
45. Macdonald J. L. Pike L. J. (2005) A simplified method for the preparation of detergent-free lipid rafts. J. Lipid Res., 46, 1061 1067.
46. McCaffrey G., Staatz W. D., Quigley C. A., Nametz N., Seelbach M. J., Campos C. R., Brooks T. A., Egleton R. D. Davis T. P. (2007) Tight junctions contain oligomeric protein assembly critical for maintaining blood-brain barrier integrity in vivo. J. Neurochem., 103, 2540 2555.
47. McKenzie J. A. Ridley A. J. (2007) Roles of Rho/ROCK and MLCK in TNF-alpha-induced changes in endothelial morphology and permeability. J. Cell. Physiol., 213, 221 228.
48. Medina R., Rahner C., Mitic L. L., Anderson J. M. Van Itallie C. M. (2000) Occludin localization at the tight junction requires the second extracellular loop. J. Membr. Biol., 178, 235 247.
49. Meyer T. N., Schwesinger C., Ye J., Denker B. M. Nigam S. K. (2001) Reassembly of the tight junction after oxidative stress depends on tyrosine kinase activity. J. Biol. Chem., 276, 22048 22055.
50. Morimoto S., Nishimura N., Terai T. et al. (2005) Rab13 mediates the continuous endocytic recycling of occludin to the cell surface. J. Biol. Chem., 280, 2220 2228.
51. Neuwelt E., Abbott N. J., Abrey L. et al. (2008) Strategies to advance translational research into brain barriers. Lancet Neurol., 7, 84 96.
52. Nusrat A., Chen J. A., Foley C. S., Liang T. W., Tom J., Cromwell M., Quan C. Mrsny R. J. (2000a) The coiled-coil domain of occludin can act to organize structural and functional elements of the epithelial tight junction. J. Biol. Chem., 275, 29816 29822.
53. Nusrat A., Parkos C. A., Verkade P., Foley C. S., Liang T. W., Innis-Whitehouse W., Eastburn K. K. Madara J. L. (2000b) Tight junctions are membrane microdomains. J. Cell Sci., 113 (Pt 10 1771 1781.
54. Nusrat A., Brown G. T., Tom J., Drake A., Bui T. T., Quan C. Mrsny R. J. (2005) Multiple protein interactions involving proposed extracellular loop domains of the tight junction protein occludin. Mol. Biol. Cell, 16, 1725 1734.
55. Ottaviano F. G., Handy D. E. Loscalzo J. (2008) Redox regulation in the extracellular environment. Circ. J., 72, 1 16.
56. Ozdamar B., Bose R., Barrios-Rodiles M., Wang H. R., Zhang Y. Wrana J. L. (2005) Regulation of the polarity protein Par6 by TGFbeta receptors controls epithelial cell plasticity. Science, 307, 1603 1609.
57. Pan W. Kastin A. J. (2007) Tumor necrosis factor and stroke: role of the blood-brain barrier. Prog. Neurobiol., 83, 363 374.
58. Paris L., Tonutti L., Vannini C. Bazzoni G. (2008) Structural organization of the tight junctions. Biochim. Biophys. Acta, 1778, 646 659.
59. Persidsky Y., Heilman D., Haorah J., Zelivyanskaya M., Persidsky R., Weber G. A., Shimokawa H., Kaibuchi K. Ikezu T. (2006) Rho-mediated regulation of tight junctions during monocyte migration across the blood-brain barrier in HIV-1 encephalitis (HIVE). Blood, 107, 4770 4780.
60. Petty M. A. Lo E. H. (2002) Junctional complexes of the blood-brain barrier: permeability changes in neuroinflammation. Prog. Neurobiol., 68, 311 323.
61. Piontek J., Winkler L., Wolburg H., Muller S. L., Zuleger N., Piehl C., Wiesner B., Krause G. Blasig I. E. (2008) Formation of tight junction: determinants of homophilic interaction between classic claudins. FASEB J., 22, 146 158.
62. Rao R. K., Basuroy S., Rao V. U., Karnaky K. J. Jr. Gupta A. (2002) Tyrosine phosphorylation and dissociation of occludin-ZO-1 and E-cadherin-beta-catenin complexes from the cytoskeleton by oxidative stress. Biochem. J., 368, 471 481.
63. Reese T. S. Karnovsky M. J. (1967) Fine structural localization of a blood-brain barrier to exogenous peroxidase. J. Cell Biol., 34, 207 217.
64. Rost B., Yachdav G. Liu J. (2004) The PredictProtein server. Nucleic Acids Res., 32, 321 326.
65. Rudajev V., Novotny J., Hejnova L., Milligan G. Svoboda P. (2005) Dominant portion of thyrotropin-releasing hormone receptor is excluded from lipid domains. Detergent-resistant and detergent-sensitive pools of TRH receptor and Gqalpha/G11alpha protein. J. Biochem. (Tokyo), 138, 111 125.
66. Sanchez-Pulido L., Martin-Belmonte F., Valencia A. Alonso M. A. (2002) MARVEL: a conserved domain involved in membrane apposition events. Trends Biochem. Sci., 27, 599 601.
67. Seelbach M. J., Brooks T. A., Egleton R. D. Davis T. P. (2007) Peripheral inflammatory hyperalgesia modulates morphine delivery to the brain: a role for P-glycoprotein. J. Neurochem., 102, 1677 1690.
68. Seth A., Sheth P., Elias B. C. Rao R. (2007) Protein phosphatases 2A and 1 interact with occludin and negatively regulate the assembly of tight junctions in the CACO-2 cell monolayer. J. Biol. Chem., 282, 11487 11498.
69. Sheth P., Basuroy S., Li C., Naren A. P. Rao R. K. (2003) Role of phosphatidylinositol 3-kinase in oxidative stress-induced disruption of tight junctions. J. Biol. Chem., 278, 49239 49245.
70. Stamatovic S. M., Dimitrijevic O. B., Keep R. F. Andjelkovic A. V. (2006) Protein kinase Calpha-RhoA cross-talk in CCL2-induced alterations in brain endothelial permeability. J. Biol. Chem., 281, 8379 8388.
71. Swiatkowska M., Szymanski J., Padula G. Cierniewski C. S. (2008) Interaction and functional association of protein disulfide isomerase with alpha(V)beta(3) integrin on endothelial cells. FEBS J., 275, 1813 1823.
72. Tavelin S., Hashimoto K., Malkinson J., Lazorova L., Toth I. Artursson P. (2003) A new principle for tight junction modulation based on occludin peptides. Mol. Pharmacol., 64, 1530 1540.
73. Tokunaga Y., Kojima T., Osanai M., Murata M., Chiba H., Tobioka H. Sawada N. (2007) A novel monoclonal antibody against the second extracellular loop of occludin disrupts epithelial cell polarity. J. Histochem. Cytochem., 55, 735 744.
74. Van Itallie C. M. Anderson J. M. (1997) Occludin confers adhesiveness when expressed in fibroblasts. J. Cell Sci., 110 (Pt 9 1113 1121.
75. Vandenbroucke E., Mehta D., Minshall R. Malik A. B. (2008) Regulation of endothelial junctional permeability. Ann. N Y Acad. Sci., 1123, 134 145.
76. Vorbrodt A. W. Dobrogowska D. H. (2004) Molecular anatomy of interendothelial junctions in human blood-brain barrier microvessels. Folia Histochem. Cytobiol., 42, 67 75.
77. Watkins L. R. Maier S. F. (2000) The pain of being sick: implications of immune-to-brain communication for understanding pain. Annu. Rev. Psychol., 51, 29 57.
78. Watkins L. R. Maier S. F. (2005) Immune regulation of central nervous system functions: from sickness responses to pathological pain. J. Intern. Med., 257, 139 155.
79. Watkins L. R., Maier S. F. Goehler L. E. (1995) Cytokine-to-brain communication: a review and analysis of alternative mechanisms. Life Sci., 57, 1011 1026.
80. Wen H., Watry D. D., Marcondes M. C. Fox H. S. (2004) Selective decrease in paracellular conductance of tight junctions: role of the first extracellular domain of claudin-5. Mol. Cell. Biol., 24, 8408 8417.
81. Wieseler-Frank J., Maier S. F. Watkins L. R. (2005a) Central proinflammatory cytokines and pain enhancement. Neurosignals, 14, 166 174.
82. Wieseler-Frank J., Maier S. F. Watkins L. R. (2005b) Immune-to-brain communication dynamically modulates pain: physiological and pathological consequences. Brain Behav. Immun., 19, 104 111.
83. Wolka A. M., Huber J. D. Davis T. P. (2003) Pain and the blood-brain barrier: obstacles to drug delivery. Adv. Drug Deliv. Rev., 55, 987 1006.
84. Wong V. Gumbiner B. M. (1997) A synthetic peptide corresponding to the extracellular domain of occludin perturbs the tight junction permeability barrier. J. Cell Biol., 136, 399 409.
85. Xu Y., Gong B., Yang Y., Awasthi Y. C., Woods M. Boor P. J. (2007) Glutathione-S-transferase protects against oxidative injury of endothelial cell tight junctions. Endothelium, 14, 333 343.
86. Yamamoto M., Ramirez S. H., Sato S., Kiyota T., Cerny R. L., Kaibuchi K., Persidsky Y. Ikezu T. (2008) Phosphorylation of claudin-5 and occludin by rho kinase in brain endothelial cells. Am. J. Pathol., 172, 521 533.
87. Zlokovic B. V. (2008) The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron, 57, 178 201.